Professional Documents
Culture Documents
Patient Summary - AWV
Patient Summary - AWV
Patient Summary - AWV
1867 Amherst Street Suite 101 | WINCHESTER, VA 22601- 2801 | T. (540) 667- 8724 F. (540) 662- 5638
Date: 12/28/2020
Reason f or Visit
Medicare Annual Wellness Visit
After review of the completed Health Risk Assessment and the patient's medical record, and in consultation
with the patient, a Personal Preventive Services Plan was created today. A summary of recommendations for
immunizations and screening for cancer, osteoporosis, and cardiovascular disease follows and was given to
the patient:
Immunizat ions:
Influenza: 09/15/2020
Pneumonia (PCV13): 06/22/2020
Pneumonia (PCV23): due:
Tetanus (Tdap/Td): 06/05/2017
Shingles/Zoster: Shingrix recommended
12/19/2019
Please schedule all t est ing and ref erral appoint ment s as ordered by your provider. If you have
any quest ions, please call t he of f ice
I have reviewed the patient’s answers on the HRA and determined the patient can successfully perform
ADLs
I have assessed the patient’s hearing by the whisper test.RE:4/5 LE:4/5there is no evidence of hearing
impairment
I have assessed the patient’s risk of fall today through the Timed Up and Go Test. 12 sec. and determined
that the patient is at low risk for falls
She is overall stable and doing well. Her labs are reviewed.
Her medicare screens show normal memory and mood, low fall risk.
Discussed with patient recommendations of healthy diet low in carbohydrates, cardiovascular exercise 30 minutes
three times a week. Recommended staying up to date on age appropriate screenings and immunizations.
2. Dyslipidemia -
Medicat ions
Your medical records indicates you are on the following medicine. If this list is not consistent with the medications you
are taking, or if you are taking additional over-the-counter medications, please inform your provider.
Reviewed Medications
aspirin 81 mg t ablet ,delayed release 11/30/17 entered
Take 1 tablet(s) every day by oral route.
ergocalcif erol (vit amin D2) 1,250 mcg (50,000 unit ) capsule 12/18/20 filled
TAKE 1 CAPSULE BY MOUTH ONCE EVERY MONTH FOR 90 DAYS
f lut icasone propionat e 50 mcg/act uat ion nasal spray,suspension 04/07/20 filled
USE 1 SPRAY(S) IN EACH NOSTRIL ONCE DAILY
Vit als
Ht : 5 ft 1 in Standing Wt : 201 lbs 9.6 oz With BMI: 38.1
(154.94 cm) clothes (91.44 kg)
Recent Result s
Discussed t he f ollowing document s:
CMP, SERUM OR PLASMA - 12/21/20
Results:
- SODIUM: 142 NORMAL
- POTASSIUM: 4.1 NORMAL
- CHLORIDE: 105 NORMAL
- CARBON DIOXIDE: 29 NORMAL
- ANION GAP: 8.4 NORMAL
- GLUCOSE: 94 NORMAL
- BUN: 21 HIGH
- CREATININE: 0.71 NORMAL
- BUN/CREATININE RATIO: 30 NORMAL
- CALCIUM: 9.4 NORMAL
- TOTAL PROTEIN: 7.1 NORMAL
- ALBUMIN: 3.8 NORMAL
- GLOBULIN: 3.3 NORMAL
- A/G RATIO: 1.2 NORMAL
- BILIRUBIN TOTAL: 0.5 NORMAL
- ALKALINE PHOSPHATASE: 92 NORMAL
- AST (SGOT): 19 NORMAL
- ALT (SGPT): 35 NORMAL
- EGFR AFRICAN AMER: 103 NORMAL
- EGFR NON-AFRICAN AMER: 90 NORMAL
LIPID PANEL, SERUM - 12/21/20
Results:
- CHOLEST EROL: 205 HIGH
- TRIGLYCERIDES: 89 NORMAL
- HDL CHOLEST EROL: 73 HIGH
- HDL CHOLEST EROL: 73 HIGH
- LDL DIRECT : 113 HIGH
- RISK RATIO (CHOL/HDL): 2.8 NORMAL
Allergies
Please review your allergy list for accuracy. Contact your provider if this list needs to be updated.
Reviewed Allergies
NKDA
Vaccines
Here is a copy of your most up-to-date vaccination list.
Reviewed Vaccines
Vac c ine Type D ate Amt. Ro ute S ite ND C Lo t # Mfr. Exp. D ate VIS Vac c inato r
D ate o n VIS G ive n
Tdap 0 6 /0 5/17
Influe nz a
influe nz a, 0 9 /15/20 0 .7 Intramus c ular D e lto id, UJ478AB S ano fi 0 6 /30 /21 0 8/15/19 0 9 /15/20 S amantha
high-do s e , mL Le ft Pas te ur No c ito
quadrivale nt (AFP)
influe nz a, 12/13/18 0 .5 Intramus c ular Arm, UT6 375JA S ano fi 0 6 /30 /19 0 8/0 7/15 12/13/18 Jamie
inje c table , mL Le ft Pas te ur White
quadrivale nt, Uppe r
pre s e rvative
fre e
influe nz a, 12/0 4/17 0 .5 Intramus c ular D e lto id, UI876 AB S ano fi 0 6 /30 /18 0 8/0 7/15 12/0 4/17 Jo rdan
inje c table , mL Le ft Pas te ur Me rrine r
quadrivale nt,
pre s e rvative
fre e
Pne umo c o c c al
pne umo c o c c al 0 6 /22/20 0 .5 Intramus c ular D e lto id, 0 0 0 0 519 710 1 CD O 412 Pfiz e r, 0 1/31/22 10 /30 /19 0 6 /22/20 Naide li
c o njugate PCV mL Le ft Inc Re ye s
13
Demographics
Please be sure to schedule all testing and referral appointments as ordered by your provider. The annual wellness
visit is important for prevention and early detection of illness. Thank you for coming in and we hope to see you next
year!
Sincerely,
Electronically Signed by: MEGAN WILLIAMS, DO